ARDS Aridis Pharmaceuticals
WatchlistAridis Pharmaceuticals News
Aridis Pharmaceuticals: Statement of changes in beneficial ownership of securities-Director HAMILTON JOHN F
4 | Aridis Pharmaceuticals, Inc. (0001614067) (Issuer)
Aridis Pharmaceuticals: Statement of changes in beneficial ownership of securities-Director Windham-Bannister Susan Richards
4 | Aridis Pharmaceuticals, Inc. (0001614067) (Issuer)
Aridis Pharmaceuticals: Statement of changes in beneficial ownership of securities-Executive Chairman Patzer Eric
4 | Aridis Pharmaceuticals, Inc. (0001614067) (Issuer)
Aridis Pharmaceuticals: Statement of changes in beneficial ownership of securities-Officer Truong Vu
4 | Aridis Pharmaceuticals, Inc. (0001614067) (Issuer)
Aridis Pharmaceuticals: Statement of changes in beneficial ownership of securities-Officer Jafri Hasan
4 | Aridis Pharmaceuticals, Inc. (0001614067) (Issuer)
Aridis Pharmaceuticals: Statement of changes in beneficial ownership of securities-Executive Chairman Patzer Eric
4 | Aridis Pharmaceuticals, Inc. (0001614067) (Issuer)
Aridis Pharmaceuticals: Statement of changes in beneficial ownership of securities-Director HAMILTON JOHN F
4 | Aridis Pharmaceuticals, Inc. (0001614067) (Issuer)
Aridis Pharmaceuticals: Statement of changes in beneficial ownership of securities-Officer Truong Vu
4 | Aridis Pharmaceuticals, Inc. (0001614067) (Issuer)
Aridis Pharmaceuticals: Statement of changes in beneficial ownership of securities-Director Windham-Bannister Susan Richards
4 | Aridis Pharmaceuticals, Inc. (0001614067) (Issuer)
Aridis Pharmaceuticals: Statement of changes in beneficial ownership of securities-Officer Jafri Hasan
4 | Aridis Pharmaceuticals, Inc. (0001614067) (Issuer)
Aridis Pharmaceuticals: Statement of changes in beneficial ownership of securities-CFO KURLAND FRED
4 | Aridis Pharmaceuticals, Inc. (0001614067) (Issuer)
Aridis Pharmaceuticals: Statement of acquisition of beneficial ownership by individuals-Lind Global Fund II LP(8.3%),Lind Global Partners II LLC(8.3%), etc.
SC 13G | Aridis Pharmaceuticals, Inc. (0001614067) (Subject)
Aridis Pharmaceuticals: Statement of acquisition of beneficial ownership by individuals-Armistice Capital, LLC(9.99%),Steven Boyd(9.99%)
SC 13G | Aridis Pharmaceuticals, Inc. (0001614067) (Subject)
Aridis Pharmaceuticals: Statement of acquisition of beneficial ownership by individuals (Amendment)-AstraZeneca PLC(3.4%),MedImmune Limited(3.4%)
SC 13G/A | Aridis Pharmaceuticals, Inc. (0001614067) (Subject)
Aridis Pharmaceuticals: Filing D
D | Aridis Pharmaceuticals, Inc. (0001614067) (Filer)
Aridis Pharmaceuticals: Statement of acquisition of beneficial ownership by individuals-Cystic Fibrosis Foundation(19.9%)
SC 13G | Aridis Pharmaceuticals, Inc. (0001614067) (Subject)
Aridis Pharmaceuticals: Initial statement of beneficial ownership of securities-10% Owner Cystic Fibrosis Foundation
3 | Aridis Pharmaceuticals, Inc. (0001614067) (Issuer)
Aridis Pharmaceuticals: Statement of changes in beneficial ownership of securities
4 | Aridis Pharmaceuticals, Inc. (0001614067) (Issuer)
Aridis Pharmaceuticals: Statement of changes in beneficial ownership of securities
4 | Aridis Pharmaceuticals, Inc. (0001614067) (Issuer)
Aridis Pharmaceuticals: Statement of changes in beneficial ownership of securities
4 | Aridis Pharmaceuticals, Inc. (0001614067) (Issuer)